CN

Event

  • Home
  • Background
  • Who will attend
  • Agenda
  • Sponsor

5th Antibody Drugs & Novel Biological Summit

Time:2015-03-15 -03-16location:sichuan chengdoushi

From 2011, CBI Pharma held this summit in the past four years, gathering enterprises, CRO,CMO, platforms, institutions and suppliers in antibody drugs. The scale has been increased steady every year. The summit quality has been approved by insiders.

On March 10th-11th 2014 in Xiamen, the summit has been successfully held. More than 250 insiders attended the summit and topics focused on R&D and Processing. Attendees are like ZJ BIO, Genor BioPharma, Celgen Biopharmaceutical, Shanghai Henlius Biotech, Shanghai JMT-BIO, Zhejiang Hisun Pharmaceutical,BI ,WuXi AppTec, Chengdu Huasun Bio-tech and atc. The atmosphere of Communications on site are among attendees are warm.

In 2015, CBI Pharma will continue to gather industry insiders to discuss latest drug discovery techniques, how to improve drug quality. Also, panels in this summit will invite insiders to talk about biopharm ecosystem, collaboration, techniques such as biospecific antibody and ADC. CBI Pharma look forward your participation.

Event Highlights

Focus on Discovery, R&D and Quality

Analyze Latest Policy and Market Orientation

Build up International Cooperation on Techniques

 

In recent years, biologics are hot in domestic. Hot topics change from downstream processing in past few years to novel R&D. Every link draws attention in different stages.

The conference, in addition to explore production technologies,will mainly focus on novel drug discovery, Nanobodies, ADC, bispecific antibodies will be discussed.

The tumor drug and non-tumor drug will classification antibody drugs delicately. Moreover, the speeches run through drug discovery to clinical feedback from doctors, which help enterprises to have a comprehensive understanding.

M&A and collaboration in industry always draw attention from decision makers. Therefore, research from investment and consulting organizations and overseas projects will be showed, which offers business cooperation chance.

 

 

Double Academician:

Dr. Zhinan CHEN, CAE Member

Dr. Yuquan, WEI, CAS Member

Chairman Group:

 

Dr. Xinhua ZHOU, CEO, Genor Biopharma Co.,Ltd

 

Dr. Chengbin WU, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd

 

Dr. Minqiang ZHANG, Vice President of R&D, Amgen

  

Dr. Daotian FU, GM, Livzon Mabpharm Inc.

Summit Details:25 Topics 3 Panels

Part of Topics and Speakers:
Topic:Discussion Tumor Immunology
Speaker: Dr. Yuquan WEI, CAS Member
Topic:Biopharm R&D Tendency
Speaker: Dr. Zhinan CHEN, CAE Member
Topic:Bispecific T-cell Engaging Antibodies for Cancer Immunotherapy
Speaker: Dr. Mingqiang ZHANG, Vice President of Research & Development for China, Amgen
Topic:Process Optimaization Checkpoint
Speaker:Dr. Xinhua ZHOU, CEO, Genor BioPharma Co., Ltd
Topic:Characterization Analysis and Drug Quality
Speaker: Dr. Boyan ZHANG, CSO, Beijing Mabworks Biotech Co.,Ltd
Topic:Characterization of Antibody Drug Conjugates
Speaker: Dr. Chaohong HU, CEO, Shanghai Miracogen
Topic: Advanced Techniques——CART
Speaker: Dr. Zonghai LI, CEO, CARsgen Therapeutics, Ltd
Topic:Clinical Feedback with Biologics in Autoimmune Diseases
Speaker: Mr. Yi LIU, Director, West China Hospital of Sichuan University
Topic:Clinical Trials Design of Anti-cancer Drugs
Speaker:Ms. Joan SHEN, Chief Medical Officer, Hengrui
Topic:Speed up R&D Process through Platforms
Speaker: Dr. Fan KAI, General Manager, Chongqin Fujin Biopharm Co.Ltd
For more topics, please contact 86 21 5155 1610


3 Panels:

Panel: Ecosystem of Biopharm Industry in China: Collabration of R&D, Policy , Market and Capital
Panelist: Dr. Chengbin WU, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd
Dr. Guoliang YU, Venture Partner, Orbimed Venture LLC/Executive Chairman, Crown Biosicence Inc.
Panel: Upgrade Quality to Meet the New Policy Requirement
Panelist: Dr. Xinhua ZHOU, CEO, Genor BioPharma Co., Ltd
Dr. Ziyi KAN, Vice President, Livzon Mabpharm Inc.
Dr. Jin LI, Deputy Director, National Key Laboratory of Antibody Therapeutics
Dr. Zheru ZHANG, CEO, JMT-BIO
Panel:Discussion of Latest Techniques in Antibody Industry
Panelist: Dr. Wenzhi TIAN, CEO, HuaBo Biopharm Co., Ltd.
Dr. Mingqiang ZHANG, Vice President of Research & Development for China, Amgen
Dr. Zonghai LI, CEO, CARsgen Therapeutics, Ltd


1 Entitled Sponsor (Gold/Silver)

Personalized marketing plan and services

2 Entitled Pre-conference Sessions (New!)

Target customers will be gathered in an individual conference room for customized activities.

3 Gala Dinner (Exclusive)

Welcome speech, activities during the gala dinner 

 4 Luncheon(Exclusive)

Welcome speech, activities during the luncheon

5 Networking Coffee Break

We can build in options to include food, music, gifts and video displays.

6 Main Session Keynote Presentation

30-minute keynote speech during the conference 

7 Sub Session Keynote Presentation

30-minute keynote speech during the conference

8 Tabletop Booth

Present your services and material during two-day conference with high promotional exposure

9 Conference Handbag (Exclusive) 

 Company Logo and slogan displayed on conference handbags

10 Conference Notebook

 Company Logo and page displayed on the Notebook

11 Delegate Badge (Exclusive)

Company Logo displayed on delegate badges

12  Advertisement

Full-page, multicolor advertisement on conference proceedings


Contact us
For more information please contactMs. Zeng +86-021-51551610
Fax:+86-021-51552421
Email:Abbyzeng@enmore.com